Ozge Fenercioglu-Erol

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Clinical Value of 68 Ga-DOTA-Bombesin PET/CT Compared With 18 F-FDG PET/CT in the Staging of Breast Cancer.

Clinical Value of 68 Ga-DOTA-Bombesin PET/CT Compared With 18 F-FDG PET/CT in the Staging of Breast Cancer.

Journal: Clinical nuclear medicine
Published: January 27, 2026

Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Brain Metastasis of Various Tumors Using Positron Emission Tomography?

Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Brain Metastasis of Various Tumors Using Positron Emission Tomography?

Journal: Cancers
Published: August 09, 2025

The Importance of 18 F-FDG PET/CT in a Rare Case of Multiple Myeloma Presenting With Nasal Plasmacytoma.

The Importance of 18 F-FDG PET/CT in a Rare Case of Multiple Myeloma Presenting With Nasal Plasmacytoma.

Journal: Clinical nuclear medicine
Published: November 06, 2024

Primary Squamous Cell Carcinoma of the Breast With 18 F-FDG PET/CT.

Primary Squamous Cell Carcinoma of the Breast With 18 F-FDG PET/CT.

Journal: Clinical nuclear medicine
Published: October 10, 2024

The Contribution of 68 Ga-FAPI-04 PET/CT to Staging and Prognosis in Gastric Cancer.

The Contribution of 68 Ga-FAPI-04 PET/CT to Staging and Prognosis in Gastric Cancer.

Journal: Clinical nuclear medicine
Published: August 01, 2024

Dual 177 Lu-Prostate-Specific Membrane Antigen and 177 Lu-DOTATATE Therapy in Metastatic Castration-Resistant Prostate Cancer With Neuroendocrine Differentiation.

Dual 177 Lu-Prostate-Specific Membrane Antigen and 177 Lu-DOTATATE Therapy in Metastatic Castration-Resistant Prostate Cancer With Neuroendocrine Differentiation.

Journal: Clinical nuclear medicine
Published: February 27, 2024

Contribution of 68 Ga-DOTA-FAPI-04 PET/CT to Prostate Cancer Imaging : Complementary Role in PSMA-Negative Cases.

Contribution of 68 Ga-DOTA-FAPI-04 PET/CT to Prostate Cancer Imaging : Complementary Role in PSMA-Negative Cases.

Journal: Clinical nuclear medicine
Published: January 25, 2024

Pneumonia with Intense 68Ga-FAPI Uptake Mimicking Metastasis on 68Ga-FAPI PET/CT in a Patient with Rectal Cancer.

Pneumonia with Intense 68Ga-FAPI Uptake Mimicking Metastasis on 68Ga-FAPI PET/CT in a Patient with Rectal Cancer.

Journal: Molecular imaging and radionuclide therapy
Published: October 23, 2023

The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions.

The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions.

Journal: Nuclear medicine communications
Published: July 14, 2023

68 Ga-FAPI-04 PET/CT in Selected Breast Cancer Patients With Low FDG Affinity : A Head-to-Head Comparative Study.

68 Ga-FAPI-04 PET/CT in Selected Breast Cancer Patients With Low FDG Affinity : A Head-to-Head Comparative Study.

Journal: Clinical nuclear medicine
Published: June 23, 2023

68Ga-FAPI-04 PET/CT Findings in Patients with Liver Cirrhosis.

68Ga-FAPI-04 PET/CT Findings in Patients with Liver Cirrhosis.

Journal: Molecular imaging and radionuclide therapy
Published: June 20, 2023

Testicular Metastasis of Jejunal Neuroendocrine Tumor on 68Ga-DOTATATE PET/CT.

Testicular Metastasis of Jejunal Neuroendocrine Tumor on 68Ga-DOTATATE PET/CT.

Journal: Molecular imaging and radionuclide therapy
Published: June 20, 2023
Showing 1-12 of 32

Last Updated: 09/26/2026